• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤浸润淋巴细胞、组织类型与上皮性卵巢癌临床结局的相关性。

Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer.

机构信息

Lancashire Teaching Hospitals Foundation NHS Trust, Lancashire, UK.

Department of Oncology, University of Cambridge, Cambridge, UK.

出版信息

BMC Cancer. 2017 Sep 20;17(1):657. doi: 10.1186/s12885-017-3585-x.

DOI:10.1186/s12885-017-3585-x
PMID:28931370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5607562/
Abstract

BACKGROUND

There is evidence that some ovarian tumours evoke an immune response, which can be assessed by tumour infiltrating lymphocytes (TILs). To facilitate adoption of TILs as a clinical biomarker, a standardised method for their H&E visual evaluation has been validated in breast cancer.

METHODS

We sought to investigate the prognostic significance of TILs in a study of 953 invasive epithelial ovarian cancer tumour samples, both primary and metastatic, from 707 patients from the prospective population-based SEARCH study. TILs were analysed using a standardised method based on H&E staining producing a percentage score for stromal and intratumoral compartments. We used Cox regression to estimate hazard ratios of the association between TILs and survival.

RESULTS

The extent of stromal and intra-tumoral TILs were correlated in the primary tumours (n = 679, Spearman's rank correlation = 0.60, P < 0.001) with a similar correlation in secondary tumours (n = 224, Spearman's rank correlation = 0.62, P < 0.001). There was a weak correlation between stromal TIL levels in primary and secondary tumour samples (Spearman's rank correlation = 0.29, P < 0.001) and intra-tumoral TIL levels in primary and secondary tumour samples (Spearman's rank correlation = 0.19, P = 0.0094). The extent of stromal TILs differed between histotypes (Pearson chi2 (12d.f.) 54.1, P < 0.0001) with higher levels of stromal infiltration in the high-grade serous and endometriod cases. A significant association was observed for higher intratumoral TIL levels and a favourable prognosis (HR 0.74 95% CI 0.55-1.00 p = 0.047).

CONCLUSION

This study is the largest collection of epithelial ovarian tumour samples evaluated for TILs. We have shown that stromal and intratumoral TIL levels are correlated and that their levels correlate with clinical variables such as tumour histological subtype. We have also shown that increased levels of both intratumoral and stromal TILs are associated with a better prognosis; however, this is only statistically significant for intratumoral TILs. This study suggests that a clinically useful immune prognostic indicator in epithelial ovarian cancer could be developed using this technique.

摘要

背景

有证据表明,一些卵巢肿瘤会引发免疫反应,这可以通过肿瘤浸润淋巴细胞(TILs)来评估。为了促进 TILs 作为临床生物标志物的应用,已经在乳腺癌中验证了一种用于其 H&E 视觉评估的标准化方法。

方法

我们旨在通过对来自前瞻性基于人群的 SEARCH 研究的 707 名患者的 953 例原发性和转移性侵袭性上皮性卵巢癌肿瘤样本进行研究,来探讨 TILs 的预后意义。使用基于 H&E 染色的标准化方法分析 TILs,产生间质和肿瘤内部分的百分比评分。我们使用 Cox 回归估计 TILs 与生存之间的关联的风险比。

结果

在原发性肿瘤(n=679)中,间质和肿瘤内 TILs 的程度呈正相关(Spearman 秩相关=0.60,P<0.001),继发性肿瘤(n=224)也存在类似的相关性(Spearman 秩相关=0.62,P<0.001)。原发性和继发性肿瘤样本的间质 TIL 水平之间存在弱相关性(Spearman 秩相关=0.29,P<0.001),原发性和继发性肿瘤样本的肿瘤内 TIL 水平之间也存在弱相关性(Spearman 秩相关=0.19,P=0.0094)。组织类型之间间质 TILs 的程度存在差异(Pearson chi2(12d.f.)54.1,P<0.0001),高级别浆液性和子宫内膜样病例的间质浸润水平更高。较高的肿瘤内 TIL 水平与较好的预后呈显著相关(HR 0.74 95%CI 0.55-1.00 p=0.047)。

结论

本研究是评估 TILs 的最大上皮性卵巢肿瘤样本集。我们已经表明,间质和肿瘤内 TIL 水平呈正相关,并且它们的水平与肿瘤组织学亚型等临床变量相关。我们还表明,肿瘤内和间质 TIL 水平的升高与更好的预后相关;然而,这仅在肿瘤内 TIL 方面具有统计学意义。这项研究表明,使用这种技术可以开发出一种在卵巢上皮性癌中具有临床应用价值的免疫预后指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f88b/5607562/5b4ecd5e11de/12885_2017_3585_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f88b/5607562/c9ad9d47221d/12885_2017_3585_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f88b/5607562/5b4ecd5e11de/12885_2017_3585_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f88b/5607562/c9ad9d47221d/12885_2017_3585_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f88b/5607562/5b4ecd5e11de/12885_2017_3585_Fig2_HTML.jpg

相似文献

1
Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer.肿瘤浸润淋巴细胞、组织类型与上皮性卵巢癌临床结局的相关性。
BMC Cancer. 2017 Sep 20;17(1):657. doi: 10.1186/s12885-017-3585-x.
2
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.CD8+ 肿瘤浸润淋巴细胞与高级别浆液性卵巢癌生存时间的剂量-反应关系。
JAMA Oncol. 2017 Dec 1;3(12):e173290. doi: 10.1001/jamaoncol.2017.3290.
3
Profiling of Tumour-Infiltrating Lymphocytes and Tumour-Associated Macrophages in Ovarian Epithelial Cancer-Relation to Tumour Characteristics and Impact on Prognosis.卵巢上皮癌中肿瘤浸润淋巴细胞和肿瘤相关巨噬细胞的分析——与肿瘤特征的关系及对预后的影响
Int J Mol Sci. 2024 Apr 20;25(8):4524. doi: 10.3390/ijms25084524.
4
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study.在曲妥珠单抗和多西他赛基础上加用帕妥珠单抗或安慰剂治疗的晚期HER2阳性乳腺癌中的肿瘤浸润淋巴细胞:CLEOPATRA研究的回顾性分析
Lancet Oncol. 2017 Jan;18(1):52-62. doi: 10.1016/S1470-2045(16)30631-3. Epub 2016 Dec 7.
5
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.浸润淋巴细胞与不同亚型乳腺癌患者预后的关系:新辅助化疗治疗 3771 例患者的汇总分析
Lancet Oncol. 2018 Jan;19(1):40-50. doi: 10.1016/S1470-2045(17)30904-X. Epub 2017 Dec 7.
6
Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.肿瘤相关B细胞和浆细胞在上皮性卵巢癌中的预后影响
J Ovarian Res. 2016 Apr 6;9:21. doi: 10.1186/s13048-016-0232-0.
7
Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma.在苏木精-伊红染色切片上评估的基质肿瘤浸润淋巴细胞是上皮性卵巢癌和卵巢浆液性癌的独立预后因素。
Oncol Lett. 2019 May;17(5):4557-4565. doi: 10.3892/ol.2019.10095. Epub 2019 Mar 1.
8
Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer.原发性全身治疗后乳腺癌肿瘤浸润淋巴细胞亚群的变化及其预后价值。
PLoS One. 2020 May 13;15(5):e0233037. doi: 10.1371/journal.pone.0233037. eCollection 2020.
9
Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.乳腺癌中肿瘤浸润淋巴细胞的评估及其与分子亚型、肿瘤分级和分期的相关性。
Breast Dis. 2020;39(2):61-69. doi: 10.3233/BD-200442.
10
Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer.较高数量的T-bet+肿瘤浸润淋巴细胞与人类上皮性卵巢癌更好的生存率相关。
Cell Physiol Biochem. 2017;41(2):475-483. doi: 10.1159/000456600. Epub 2017 Jan 30.

引用本文的文献

1
Association of Tumor-Infiltrating Lymphocytes and Inflammation Status with Survival Outcome in Patients with High-Grade Serous Ovarian Carcinoma.高级别浆液性卵巢癌患者肿瘤浸润淋巴细胞及炎症状态与生存结局的相关性
Cancers (Basel). 2025 Jul 8;17(14):2269. doi: 10.3390/cancers17142269.
2
The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer.DNA 甲基化转移酶 1(DNAM-1)作为促进自然杀伤细胞介导的卵巢癌杀伤作用的因子的出现。
Front Immunol. 2025 Jan 6;15:1477781. doi: 10.3389/fimmu.2024.1477781. eCollection 2024.
3
Profiling of Tumour-Infiltrating Lymphocytes and Tumour-Associated Macrophages in Ovarian Epithelial Cancer-Relation to Tumour Characteristics and Impact on Prognosis.

本文引用的文献

1
Size matters: Survival benefit conferred by intratumoral T cells is dependent on surgical outcome, treatment sequence and T cell differentiation.大小很重要:肿瘤内T细胞赋予的生存益处取决于手术结果、治疗顺序和T细胞分化。
Oncoimmunology. 2016 Jan 4;5(5):e1122863. doi: 10.1080/2162402X.2015.1122863. eCollection 2016 May.
2
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.程序性死亡配体1(PD-L1)表达与高级别浆液性卵巢癌中的肿瘤浸润性T细胞及良好预后相关。
Gynecol Oncol. 2016 May;141(2):293-302. doi: 10.1016/j.ygyno.2016.03.008. Epub 2016 Mar 16.
3
卵巢上皮癌中肿瘤浸润淋巴细胞和肿瘤相关巨噬细胞的分析——与肿瘤特征的关系及对预后的影响
Int J Mol Sci. 2024 Apr 20;25(8):4524. doi: 10.3390/ijms25084524.
4
Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center.新辅助化疗对可切除胃癌肿瘤浸润淋巴细胞的影响:来自西方学术中心的分析
Cancers (Basel). 2024 Apr 7;16(7):1428. doi: 10.3390/cancers16071428.
5
Adoptive T cell therapy for ovarian cancer.卵巢癌的过继性 T 细胞疗法。
Gynecol Oncol. 2024 Jul;186:77-84. doi: 10.1016/j.ygyno.2024.04.001. Epub 2024 Apr 10.
6
Tumor immunity: A brief overview of tumor‑infiltrating immune cells and research advances into tumor‑infiltrating lymphocytes in gynecological malignancies (Review).肿瘤免疫:肿瘤浸润免疫细胞概述及妇科恶性肿瘤中肿瘤浸润淋巴细胞的研究进展(综述)
Exp Ther Med. 2024 Feb 26;27(4):166. doi: 10.3892/etm.2024.12453. eCollection 2024 Apr.
7
Machine Learning Quantification of Intraepithelial Tumor-Infiltrating Lymphocytes as a Significant Prognostic Factor in High-Grade Serous Ovarian Carcinomas.机器学习量化上皮内肿瘤浸润淋巴细胞作为高级别浆液性卵巢癌的一个显著预后因素。
Int J Mol Sci. 2023 Nov 7;24(22):16060. doi: 10.3390/ijms242216060.
8
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.上皮性卵巢癌被表达 CD39、PD-1、TIM-3、CD137 的活化效应 T 细胞浸润,这些 T 细胞与癌细胞和髓样细胞相互作用。
Front Immunol. 2023 Oct 4;14:1212444. doi: 10.3389/fimmu.2023.1212444. eCollection 2023.
9
Immunodiagnosis - the promise of personalized immunotherapy.免疫诊断——个性化免疫治疗的前景。
Front Immunol. 2023 Jul 13;14:1216901. doi: 10.3389/fimmu.2023.1216901. eCollection 2023.
10
Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance.免疫细胞与血小板在卵巢癌微环境中的相互作用及其预后意义。
Int J Mol Sci. 2023 May 25;24(11):9279. doi: 10.3390/ijms24119279.
Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer.
CD103和CD3联合免疫评分可识别高级别浆液性卵巢癌的长期存活者。
Int J Gynecol Cancer. 2016 May;26(4):671-9. doi: 10.1097/IGC.0000000000000672.
4
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.BRCA1/2基因突变状态与高级别浆液性卵巢癌新抗原负荷、肿瘤浸润淋巴细胞数量及PD-1/PD-L1表达的相关性及预后意义
Oncotarget. 2016 Mar 22;7(12):13587-98. doi: 10.18632/oncotarget.7277.
5
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer.肿瘤浸润浆细胞与三级淋巴结构、细胞毒性 T 细胞应答相关,并与卵巢癌的良好预后相关。
Clin Cancer Res. 2016 Jun 15;22(12):3005-15. doi: 10.1158/1078-0432.CCR-15-2762. Epub 2016 Jan 13.
6
Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.程序性细胞死亡蛋白-1(PD-1)和PD-配体1(PD-L1)在卵巢高级别浆液性癌的癌细胞及肿瘤浸润淋巴细胞中的表达对预后的影响
Oncotarget. 2016 Jan 12;7(2):1486-99. doi: 10.18632/oncotarget.6429.
7
T cell exclusion, immune privilege, and the tumor microenvironment.T 细胞排斥、免疫特权和肿瘤微环境。
Science. 2015 Apr 3;348(6230):74-80. doi: 10.1126/science.aaa6204.
8
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.2014年国际肿瘤浸润淋巴细胞(TILs)工作组对乳腺癌中肿瘤浸润淋巴细胞的评估建议
Ann Oncol. 2015 Feb;26(2):259-71. doi: 10.1093/annonc/mdu450. Epub 2014 Sep 11.
9
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.迈向“免疫评分”在肿瘤良恶性分类中的引入。
J Pathol. 2014 Jan;232(2):199-209. doi: 10.1002/path.4287.
10
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.